{"title":"超越裂谷:制药和制药业的未来","authors":"Jonathan C. Peck","doi":"10.3109/J058V18N02_09","DOIUrl":null,"url":null,"abstract":"SUMMARYThe rift between pharmacy and industry can block their co-evolution from suppliers of drugs to health care providers. This article identifies key steps that the profession of pharmacy and its industry partners can take to heal the rift and advance mutual interests. One step is to develop a shared agenda for building a personalized risk infrastructure with defined roles for both professionals and companies. A second is for pharmacy leaders to identify how they can collaborate with industry in the Pharma 2029 agenda that shifts all of health care toward preemption and prevention. Patient health can benefit when pharmacy and industry scientifically collaborate in a trusting relationship.","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"1 1","pages":"91-103"},"PeriodicalIF":0.0000,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Beyond the Rift: The Future of Pharmacy and the Pharmaceutical Industry\",\"authors\":\"Jonathan C. Peck\",\"doi\":\"10.3109/J058V18N02_09\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"SUMMARYThe rift between pharmacy and industry can block their co-evolution from suppliers of drugs to health care providers. This article identifies key steps that the profession of pharmacy and its industry partners can take to heal the rift and advance mutual interests. One step is to develop a shared agenda for building a personalized risk infrastructure with defined roles for both professionals and companies. A second is for pharmacy leaders to identify how they can collaborate with industry in the Pharma 2029 agenda that shifts all of health care toward preemption and prevention. Patient health can benefit when pharmacy and industry scientifically collaborate in a trusting relationship.\",\"PeriodicalId\":16734,\"journal\":{\"name\":\"Journal of Pharmaceutical Marketing & Management\",\"volume\":\"1 1\",\"pages\":\"91-103\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Marketing & Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3109/J058V18N02_09\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Marketing & Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/J058V18N02_09","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Beyond the Rift: The Future of Pharmacy and the Pharmaceutical Industry
SUMMARYThe rift between pharmacy and industry can block their co-evolution from suppliers of drugs to health care providers. This article identifies key steps that the profession of pharmacy and its industry partners can take to heal the rift and advance mutual interests. One step is to develop a shared agenda for building a personalized risk infrastructure with defined roles for both professionals and companies. A second is for pharmacy leaders to identify how they can collaborate with industry in the Pharma 2029 agenda that shifts all of health care toward preemption and prevention. Patient health can benefit when pharmacy and industry scientifically collaborate in a trusting relationship.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
